Mitant 12.5mg Capsule

About Mitant 12.5mg Capsule

Mitant 12.5mg Capsule contains Sunitinib, an oral multikinase inhibitor used primarily in the treatment of certain types of cancer, including renal cell carcinoma, gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors.

Since interactions can happen, let your doctor know if you have problems with your heart, liver, kidneys, or blood disorders. Effective contraception is crucial throughout therapy, and this medication is not advised during pregnancy or lactation.

Brand Name: Mitant

Composition: Sunitinib

Mechanism of Action:

VEGFR (vascular endothelial growth factor receptor), PDGFR (platelet-derived growth factor receptor), KIT, and other receptor tyrosine kinases implicated in tumor growth and angiogenesis (the creation of new blood vessels) are among the many that sunitinib inhibits. Sunitinib aids in halting the growth and metastasis of the tumor by blocking these pathways.

Uses:

• Metastatic Renal Cell Carcinoma
• Gastrointestinal Cancer
• Pancreatic Cancer

Dosage and Administration:

Taken orally with or without food. Instead of chewing or crushing the capsule, it is best to swallow it whole. Depending on adverse effects, the dosage may be changed.

 Side Effects:

• Diarrhea
• Nausea
• Vomiting
• Fever
• Headache
• Abdominal pain
• Leukopenia (low white blood cell count)
• Anemia
• Headache
• Dizziness
• Fatigue